TytoCare Receives FDA Clearance for AI Lung Crackle Detection
30 Julio 2024 - 8:00AM
TytoCare, a virtual care company enabling accessible, high-quality
primary care from home, announced today that it has received an
additional FDA clearance for a new AI-powered diagnostic
capability, Tyto Insights for Crackle Detection. This capability,
which is built on TytoCare’s database of lung sound recordings and
driven by an innovative, AI-based algorithm, joins TytoCare’s
existing suite of diagnostic tools, including Tyto Insights for
Wheeze Detection, which was cleared by the FDA in 2023.
Tyto Insights for Crackle Detection is designed to help
clinicians detect lung crackles in adults and children over two
years old that may need attention during a virtual clinic visit. By
identifying lung crackles in a virtual visit, providers can direct
patients to the most appropriate follow-up treatment to manage
their health.
“The integration of AI into our diagnostic tools significantly
enhances clinician efficiency and speed to diagnosis,” said Dedi
Gilad, CEO and Co-Founder of TytoCare. “With our new AI-powered
crackle detection algorithm, which was trained using data validated
by pulmonologists.”
Tyto Insights for Crackle Detection will be added to TytoCare’s
Home Smart Clinic and Pro Smart Clinic solutions in the coming
months. During a virtual visit, the TytoCare solution uses this AI
algorithm to analyze lung acoustic signals and identify exams with
potential abnormal sounds indicative of crackles. If crackles are
detected, the exam content is flagged, and providers are alerted to
the presence of these abnormal lung sounds.
TytoCare’s Home and Pro Smart Clinic are the only solutions that
can replicate the full experience of the clinic virtually,
including allowing clinicians to listen to a patient’s lungs, on
top of the devices’ existing capabilities to remotely perform exams
of the ears, throat, heart, and skin. To date, TytoCare has found
that respiratory diagnoses constitute over 40 percent of all
diagnoses made using its virtual care solution, reflecting the
prevalence of acute and chronic respiratory conditions.
The new feature, which will be available in September, is the
latest in a line of improvements to TytoCare’s offerings, with more
AI capabilities to be submitted for clearance and rolled out to
users in the coming months. Most recently, TytoCare launched a
major update to increase digital health integration capabilities,
facilitate patient-provider exam sharing, and add pre-visit exams
and a patient onboarding chatbot.
About TytoCareTytoCare is a virtual healthcare
company that enables leading health plans and providers to deliver
remote healthcare to the whole family through its Home Smart
Clinic. Combining a cutting-edge, easy-to-use, FDA-cleared device
with embedded AI, the Home Smart Clinic enables the whole family to
conduct remote physical exams with a doctor, replicating in-clinic
exams for immediate answers from home. TytoCare drives utilization
rates that are five times higher than traditional telehealth
services; reduces the total cost of care by an average of five
percent; diverts ED visits by an average of 10.8 percent; and has a
high average NPS of 83. The Home Smart Clinic includes Tyto
Engagement Labs™, a proven framework of engagement journeys
designed for the successful deployment and adoption of the
solution. To complete its offering, TytoCare also provides the Pro
Smart Clinic, for professional settings outside the home to serve
rural clinics, schools, workplaces, and more. TytoCare serves over
250 major health systems and health plans in the U.S., Europe,
Asia, Latin America, and the Middle East.
Press Contact:
Laura Werber
TytoCare@crosscutstrategies.com